1,3-Benzodioxolyl-N-ethylpentanamine

EBDP
Clinical data
Other names	EBDP; 3,4-Methylenedioxy-α-propyl-N-ethyl-2-phenethylamine
Routes of; administration	Oral
ATC code	None;
Pharmacokinetic data
Duration of action	Unknown
Identifiers
	IUPAC name 1-(2H-1,3-benzodioxol-5-yl)-N-ethylpentan-2-amine;
CAS Number	952016-47-6 ;
PubChem CID	44719567;
ChemSpider	21106304;
UNII	198YKP5KCQ;
CompTox Dashboard (EPA)	DTXSID00660365 ;
Chemical and physical data
Formula	C14H21NO2
Molar mass	235.327 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1=C2C(=CC=C1CC(CCC)NCC)OCO2;
	InChI InChI=1S/C14H21NO2/c1-3-5-12(15-4-2)8-11-6-7-13-14(9-11)17-10-16-13/h6-7,9,12,15H,3-5,8,10H2,1-2H3; Key:YIJZJPAWMJJXQD-UHFFFAOYSA-N;

'1,3-Benzodioxolyl-N-ethylpentanamine (N-ethyl-1,3-benzodioxolylpentanamine; EBDP; ethyl-K; 3,4-methylenedioxy-N-ethyl-α-propylphenethylamine) is a psychoactive drug and member of the phenethylamine chemical class which acts as an entactogen, psychedelic, and stimulant. It is the N-ethyl analog of 1,3-benzodioxolylpentanamine (BDP; K). Ethyl-K was first synthesized by Alexander Shulgin. In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 40 mg and the duration is unknown.^[1]^[2] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Ethyl-K.

Society and culture